Form 4: GoodRx Holdings Chief Accounting Officer Romin Nabiey Reports Stock and Option Awards
SEC Form 4
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the acquisition of restricted stock units and stock options.
Summary
- Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, filed a Form 4 with the SEC.
- The filing reports the acquisition of 35,716 restricted stock units and 51,462 stock options on March 12, 2024.
- The restricted stock units and stock options vest in installments beginning June 8, 2024, and continuing quarterly for 15 quarters.
- Nabiey directly owns 115,997 shares of Class A Common Stock.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing detailing stock and option awards, which is generally neutral. The awards suggest a positive outlook from the company regarding the executive's performance and the company's future.
Positives
- The grant of restricted stock units and stock options suggests confidence in the company's future performance.
Future Outlook
The vesting schedule of the restricted stock units and stock options indicates a long-term incentive plan for the Chief Accounting Officer.
Industry Context
Form 4 filings are routine disclosures of insider transactions and are common in the pharmaceutical and healthcare technology industries.
Comparison to Industry Standards
- Stock option and RSU grants are a standard component of compensation packages for executives in publicly traded companies, including those in the tech and healthcare sectors.
- Companies like Teladoc, CVS Health, and UnitedHealth Group also utilize similar equity-based compensation to align executive interests with shareholder value.
Stakeholder Impact
- The stock and option awards align the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the Chief Accounting Officer.
Key Dates
| Date | Description |
|---|---|
| 03/12/2024 | Date of transaction for restricted stock units and stock options acquisition. |
| 03/12/2024 | Grant date of stock options with an expiration date of 03/12/2034. |
| 03/14/2024 | Date of Form 4 filing. |
| 06/08/2024 | First vesting date for both restricted stock units and stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.